研究发现，减肥药 Wegovy 和 Ozempic 会增加麻醉手术期间呕吐的风险。 Weight-loss drugs Wegovy and Ozempic increase vomiting risk during surgery under anesthesia, study finds.
最近的一项研究报告称，减肥药物 Wegovy 和 Ozempic 属于 GLP-1 受体激动剂，可能会增加麻醉手术期间呕吐的风险。 Weight-loss drugs Wegovy and Ozempic, classified as GLP-1 receptor agonists, can increase the risk of vomiting during surgery under anesthesia, a recent study reports. 这些药物会减缓消化，导致食物在胃中停留更长时间。 These drugs slow digestion, causing food to remain in the stomach longer. 因此，56% 服用此类药物的患者在手术期间胃中仍有大量食物，而未服用此类药物的患者为 19%，这揭示了麻醉下潜在的误吸风险。 Consequently, 56% of patients on such drugs still had significant amounts of food in their stomach during surgery, compared to 19% not taking them, revealing potential aspiration risk under anesthesia.